Literature DB >> 25979580

Guillain-Barré syndrome.

Vibhuti Ansar1, Nojan Valadi2.   

Abstract

Guillain-Barré syndrome and its clinical variants are a group of rapidly progressing, potentially debilitating neurologic disorders that may have significant morbidity/mortality if left unrecognized or untreated. The most common symptoms include ascending limb weakness and paralysis, which may progress to respiratory failure. Diagnosis is made clinically with laboratory testing. Several treatment options exist, including plasma exchange and intravenous immunoglobulin administration. Most cases may resolve without sequelae, but those that do not may leave behind significant persistent debility.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute inflammatory demyelinating polyradiculoneuropathy (AIDP); Acute motor axonal neuropathy; Demyelinating syndrome; Guillain-Barré syndrome; Miller Fisher syndrome

Mesh:

Substances:

Year:  2015        PMID: 25979580     DOI: 10.1016/j.pop.2015.01.001

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  13 in total

Review 1.  Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere.

Authors:  Helen M Lazear; Michael S Diamond
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

2.  IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome.

Authors:  Jing Peng; Hui Zhang; Peidong Liu; Min Chen; Bing Xue; Rui Wang; Jifei Shou; Juanfeng Qian; Zhikang Zhao; Yanmeng Xing; Hongbo Liu
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

Review 3.  Zika virus genome biology and molecular pathogenesis.

Authors:  Anyou Wang; Stephanie Thurmond; Leonel Islas; Kingyung Hui; Rong Hai
Journal:  Emerg Microbes Infect       Date:  2017-03-22       Impact factor: 7.163

4.  Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon.

Authors:  Darci R Smith; Bradley Hollidge; Sharon Daye; Xiankun Zeng; Candace Blancett; Kyle Kuszpit; Thomas Bocan; Jeff W Koehler; Susan Coyne; Tim Minogue; Tara Kenny; Xiaoli Chi; Soojin Yim; Lynn Miller; Connie Schmaljohn; Sina Bavari; Joseph W Golden
Journal:  PLoS Negl Trop Dis       Date:  2017-01-09

5.  Clinical, Serological, and Molecular Observations from a Case Series Study during the Asian Lineage Zika Virus Outbreak in Grenada during 2016.

Authors:  Marco Brenciaglia; Trevor P Noël; Paul J Fields; Satesh Bidaisee; Todd E Myers; William M Nelson; Neeraja Venkateswaran; Kodumudi Venkateswaran; Nishanth Parameswaran; Avi Bahadoor; Katherine Yearwood; Veronica Mapp-Alexander; George Mitchell; A Desiree LaBeaud; Calum N L Macpherson
Journal:  Can J Infect Dis Med Microbiol       Date:  2018-02-01       Impact factor: 2.471

6.  A Rare Axonal Variant of Guillain-Barré Syndrome following Elective Spinal Surgery.

Authors:  Jessica R Dowling; Thomas J Dowling
Journal:  Case Rep Orthop       Date:  2018-08-07

Review 7.  Hepatitis E virus-associated Guillain-Barre syndrome: Revision of the literature.

Authors:  Hang Liu; Ying Ma
Journal:  Brain Behav       Date:  2019-12-11       Impact factor: 2.708

8.  Clinical characteristics and outcomes of patients with overlapping Miller Fisher syndrome and myasthenia gravis.

Authors:  Jun-Liang Yuan; Yan Xing; Wen-Li Hu
Journal:  Arch Med Sci       Date:  2019-12-31       Impact factor: 3.318

9.  Clinical Features and Outcome of Guillain-Barré Syndrome in Children.

Authors:  Jafar Nasiri; Mohamadreza Ghazavi; Omid Yaghini; Mohamad Chaldavi
Journal:  Iran J Child Neurol       Date:  2018

Review 10.  The clinical features of patients concurrent with Guillain-Barre syndrome and myasthenia gravis.

Authors:  Junliang Yuan; Juan Zhang; Bingwei Zhang; Wenli Hu
Journal:  Neurosciences (Riyadh)       Date:  2018-01       Impact factor: 0.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.